Methods matter – Tailoring SARS-CoV-2 antibody targets to vaccination status

Individuals who have been vaccinated for COVID19 should have IgG antibody in response to the specific antigen that is the target in the vaccine development. There are several options for targeted COVID19 antigen, but most manufacturers have focused on the spike protein. Using our understanding of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapp, Alexandra R., Ogunbileje, John O., Djouodo-Nemzou, Diane, Okorodudu, Anthony O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052504/
https://www.ncbi.nlm.nih.gov/pubmed/33872607
http://dx.doi.org/10.1016/j.cca.2021.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052504/
https://www.ncbi.nlm.nih.gov/pubmed/33872607
http://dx.doi.org/10.1016/j.cca.2021.04.009

Ejemplares similares